By Kisean Joseph
The Medicinal Cannabis Authority (MCA) applied several reforms to boost industry accessibility while strengthening regional links throughout 2024, according to Chief Executive Officer (CEO) of the MCA, Regis Burton.
The changes signal a shift toward collaborative growth and standardized regulations across the Caribbean region.
In a review of the authorities’ calendar for the past year, Burton highlighted the introduction of a new licensing structure designed to make market entry more affordable for local entrepreneurs.
“We started 2024 by answering the cries of many people. The fees could sometimes look very high, but if you come together as a group, you split the cost, then the fees are more realistic for an investment,” Burton said.
With these reforms, a new joint “growth” license offers incentives for group applications. Under the new framework, when five or more Antiguans join forces, they receive an extended five-year license instead of the standard two-year term, along with an 80 percent discount on licensing fees, Burton said.
This initiative was formally enacted through the 2024 amendments to existing regulations.
Regional cooperation emerged as another key focus area for the MCA. The authority has established partnerships with neighboring territories, including St Kitts and Nevis, to develop a unified approach to medicinal cannabis regulation.
A major highlight of the year was the inaugural “Would That Be Cannabis Festival”, a three-day educational conference combining research presentations, wellness discussions, and cultural celebrations. The second edition of the annual event returns in April this year and represents the MCA’s commitment to public education and cultural integration.
However, Burton acknowledged several challenges facing the industry, particularly regarding public safety and product quality control. The MCA has been working closely with authorities from the Customs and Excise Division to monitor the influx of hemp-derived products, many of which fall into regulatory gray areas.
“We don’t want to risk our country to any poor-quality cannabis products, especially in this early stage,” Burton said. He added that there’s a need for stringent quality control measures and the authority has been particularly vigilant about unregulated hemp products entering the market, as these often lack approval by the Food and Drug Administration (FDA) and may not meet local safety standards.
The MCA plans to continue its focus on education and regulatory refinement. Burton therefore underscored that the ultimate goal extends beyond business development.
“Our real focus is how do we use cannabis to improve the health and wellness of our country and society.”
About The Author
